CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response.
CRISPR基因敲除筛选可识别胰腺癌中的组合药物靶点并模拟细胞药物反应
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-018-06676-2
Szlachta Karol, Kuscu Cem, Tufan Turan, Adair Sara J, Shang Stephen, Michaels Alex D, Mullen Matthew G, Fischer Natasha Lopes, Yang Jiekun, Liu Limin, Trivedi Prasad, Stelow Edward B, Stukenberg P Todd, Parsons J Thomas, Bauer Todd W, Adli Mazhar
